A new vaccine against Meningitis B has been approved for use in the UK.
The vaccine, developed by pharmaceutical giant Bexsero, received its licence from the European Commission today.
Meningitis UK is urging the Government to make the vaccine part of the NHS childhood immunisation schedule, so that it "will save as many lives as possible".
The new vaccine is the first to be licensed specifically for Meningitis B, one of the deadliest and most common strains of the disease.
Meningitis is a deadly disease that can kill in just four hours. Knowing the symptoms and acting fast can save lives.